Literature DB >> 20547545

I-Ag7 is subject to post-translational chaperoning by CLIP.

Cornelia H Rinderknecht1, Ning Lu, Oliver Crespo, Phi Truong, Tieying Hou, Nan Wang, Narendiran Rajasekaran, Elizabeth D Mellins.   

Abstract

Several MHC class II alleles linked with autoimmune diseases form unusually low-stability complexes with class II-associated invariant chain peptides (CLIP), leading us to hypothesize that this is an important feature contributing to autoimmune pathogenesis. We recently demonstrated a novel post-endoplasmic reticulum (ER) chaperoning role of the CLIP peptides for the murine class II allele I-E(d). In the current study, we tested the generality of this CLIP chaperone function using a series of invariant chain (Ii) mutants designed to have varying CLIP affinity for I-A(g7). In cells expressing these Ii CLIP mutants, I-A(g7) abundance, turnover and antigen presentation are all subject to regulation by CLIP affinity, similar to I-E(d). However, I-A(g7) undergoes much greater quantitative changes than observed for I-E(d). In addition, we find that Ii with a CLIP region optimized for I-A(g7) binding may be preferentially assembled with I-A(g7) even in the presence of higher levels of wild-type Ii. This finding indicates that, although other regions of Ii interact with class II, CLIP binding to the groove is likely to be a dominant event in assembly of nascent class II molecules with Ii in the ER.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20547545      PMCID: PMC2908477          DOI: 10.1093/intimm/dxq056

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  54 in total

1.  Determination of the HLA-DM interaction site on HLA-DR molecules.

Authors:  R C Doebele; R Busch; H M Scott; A Pashine; E D Mellins
Journal:  Immunity       Date:  2000-10       Impact factor: 31.745

2.  In APCs, the autologous peptides selected by the diabetogenic I-Ag7 molecule are unique and determined by the amino acid changes in the P9 pocket.

Authors:  Anish Suri; Ilan Vidavsky; Koen van der Drift; Osami Kanagawa; Michael L Gross; Emil R Unanue
Journal:  J Immunol       Date:  2002-02-01       Impact factor: 5.422

Review 3.  Nonclassical MHC class II molecules.

Authors:  C Alfonso; L Karlsson
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

4.  Modelling of the MHC II allele I-A(g7) of NOD mouse: pH-dependent changes in specificity at pockets 9 and 6 explain several of the unique properties of this molecule.

Authors:  A K Moustakas; J Routsias; G K Papadopoulos
Journal:  Diabetologia       Date:  2000-05       Impact factor: 10.122

5.  Rheumatoid arthritis (RA)-associated HLA-DR alleles form less stable complexes with class II-associated invariant chain peptide than non-RA-associated HLA-DR alleles.

Authors:  N S Patil; A Pashine; M P Belmares; W Liu; B Kaneshiro; J Rabinowitz; H McConnell; E D Mellins
Journal:  J Immunol       Date:  2001-12-15       Impact factor: 5.422

6.  Nonobese diabetic mice display elevated levels of class II-associated invariant chain peptide associated with I-Ag7 on the cell surface.

Authors:  A Bhatnagar; P J Milburn; M Lobigs; R V Blanden; A M Gautam
Journal:  J Immunol       Date:  2001-04-01       Impact factor: 5.422

7.  The I-Ag7 MHC class II molecule linked to murine diabetes is a promiscuous peptide binder.

Authors:  T Stratmann; V Apostolopoulos; V Mallet-Designe; A L Corper; C A Scott; I A Wilson; A S Kang; L Teyton
Journal:  J Immunol       Date:  2000-09-15       Impact factor: 5.422

8.  Identification of MHC class II-restricted peptide ligands, including a glutamic acid decarboxylase 65 sequence, that stimulate diabetogenic T cells from transgenic BDC2.5 nonobese diabetic mice.

Authors:  V Judkowski; C Pinilla; K Schroder; L Tucker; N Sarvetnick; D B Wilson
Journal:  J Immunol       Date:  2001-01-15       Impact factor: 5.422

9.  Peptide analysis, stability studies, and structural modeling explain contradictory peptide motifs and unique properties of the NOD mouse MHC class II molecule H2-A(g7).

Authors:  Christian Münz; Matthias Hofmann; Kenji Yoshida; Antonis K Moustakas; Hitoshi Kikutani; Stefan Stevanoviç; George K Papadopoulos; Hans-Georg Rammensee
Journal:  Eur J Immunol       Date:  2002-08       Impact factor: 5.532

10.  Germinal center B cells regulate their capability to present antigen by modulation of HLA-DO.

Authors:  Kim S Glazier; Sandra B Hake; Helen M Tobin; Amy Chadburn; Elaine J Schattner; Lisa K Denzin
Journal:  J Exp Med       Date:  2002-04-15       Impact factor: 14.307

View more
  9 in total

1.  γδ T cells recognize the insulin B:9-23 peptide antigen when it is dimerized through thiol oxidation.

Authors:  M Kemal Aydintug; Li Zhang; Chao Wang; Dongchun Liang; J M Wands; Aaron W Michels; Brooke Hirsch; Brian J Day; Gongyi Zhang; Deming Sun; George S Eisenbarth; Rebecca L O'Brien; Willi K Born
Journal:  Mol Immunol       Date:  2014-05-20       Impact factor: 4.407

2.  Epitope Selection for HLA-DQ2 Presentation: Implications for Celiac Disease and Viral Defense.

Authors:  Shu-Chen Hung; Tieying Hou; Wei Jiang; Nan Wang; Shuo-Wang Qiao; I-Ting Chow; Xiaodan Liu; Sjoerd H van der Burg; David M Koelle; William W Kwok; Ludvig M Sollid; Elizabeth D Mellins
Journal:  J Immunol       Date:  2019-03-29       Impact factor: 5.422

3.  Comparison of transduction efficiency among various lentiviruses containing GFP reporter in bone marrow hematopoietic stem cell transplantation.

Authors:  Nan Wang; Narendiran Rajasekaran; Tieying Hou; Leszek Lisowski; Elizabeth D Mellins
Journal:  Exp Hematol       Date:  2013-08-14       Impact factor: 3.084

4.  An insertion mutant in DQA1*0501 restores susceptibility to HLA-DM: implications for disease associations.

Authors:  Tieying Hou; Henriette Macmillan; Zhenjun Chen; Catherine L Keech; Xi Jin; John Sidney; Michael Strohman; Taejin Yoon; Elizabeth D Mellins
Journal:  J Immunol       Date:  2011-07-20       Impact factor: 5.422

5.  Transgene expression in various organs post BM-HSC transplantation.

Authors:  Nan Wang; Narendiran Rajasekaran; Tieying Hou; Elizabeth D Mellins
Journal:  Stem Cell Res       Date:  2013-11-02       Impact factor: 2.020

Review 6.  On the perils of poor editing: regulation of peptide loading by HLA-DQ and H2-A molecules associated with celiac disease and type 1 diabetes.

Authors:  Robert Busch; Alessandra De Riva; Andreas V Hadjinicolaou; Wei Jiang; Tieying Hou; Elizabeth D Mellins
Journal:  Expert Rev Mol Med       Date:  2012-07-06       Impact factor: 5.600

7.  Immunological Basis for Rapid Progression of Diabetes in Older NOD Mouse Recipients Post BM-HSC Transplantation.

Authors:  Nan Wang; Narendiran Rajasekaran; Tieying Hou; Claudia Macaubas; Elizabeth D Mellins
Journal:  PLoS One       Date:  2015-05-28       Impact factor: 3.240

8.  Accelerated turnover of MHC class II molecules in nonobese diabetic mice is developmentally and environmentally regulated in vivo and dispensable for autoimmunity.

Authors:  Alessandra De Riva; Mark C Varley; Leslie J Bluck; Anne Cooke; Michael J Deery; Robert Busch
Journal:  J Immunol       Date:  2013-05-15       Impact factor: 5.422

Review 9.  MHC Class II Protein Turnover In vivo and Its Relevance for Autoimmunity in Non-Obese Diabetic Mice.

Authors:  Alessandra De Riva; Robert Busch
Journal:  Front Immunol       Date:  2013-11-25       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.